Nan Fung Group has established Pivotal Bioventure Partners China to build a concentrated portfolio of high-quality life science assets and nurture them from inception to exit
Incubation has become the prevailing trend among early-stage China healthcare investors. Lilly Asia Ventures pursues an incubation model whereby the GP launches new start-ups internally or backs entrepreneurs...
Investors see opportunity in bringing a promising currency exchange-focused fintech model from Europe into Southeast Asia. Singapore-focused YouTrip is the region’s first mover in this niche
Traditionally the overlooked, underappreciated or misrepresented facet of ESG, governance is gaining prominence in emerging markets private equity as investors reassess risk exposure
Capital has poured into China’s online education sector in recent years, but with losses mounting and valuations called into question, investors are finding that not all business models are created equal
Endiya Partners, an early-stage VC investor based in India, has achieved a first close of $40 million for its second fund. The target is $70 million.